Androgenic Receptor Sensitivity denotes the efficiency with which androgen hormones, such as testosterone and dihydrotestosterone, bind to and activate their cognate nuclear receptors within target cells. High sensitivity indicates a robust cellular response to circulating androgens, while low sensitivity suggests receptor downregulation or functional impairment. This metric is critical for understanding androgen action independent of total hormone levels.
Origin
This term arises from combining “Androgenic,” relating to male sex hormones and their effects, with “Receptor Sensitivity,” a concept borrowed from pharmacology describing the dose-response relationship of a ligand to its binding site. In clinical endocrinology, it quantifies the effectiveness of androgen signaling within target tissues like muscle or prostate. The focus is purely on the downstream cellular interaction.
Mechanism
The mechanism involves the binding of an androgen to its intracellular receptor, leading to receptor dimerization and translocation to the nucleus. Once in the nucleus, the complex binds to specific DNA sequences, modulating gene transcription related to growth and differentiation. Improving sensitivity often involves reducing inflammatory signaling that can interfere with this nuclear translocation process.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.